TAYSHA GENE THERAPIES INC

TSHANASDAQ

🏆 #1804 by market capEarnings Nov 10US Equity

$339.01▼ $14.20 (−4.19%)

Simulated price

1h—

24h▼ 4.2%

7d—

14d—

30d—

1y—

🏦Market Cap

$2.14B

Small Cap

📈Revenue Growth (YoY)

+3.4%

Slowing

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

208.5x

Expensive

Otter Score

48

Weak

Earnings

Q2 · 2026After-MarketReported 2026-08-11

Earnings Per Share

Actual

-0.13

Expected

-0.12

miss

−9.30%

Revenue

Actual

$0.00

Expected

$693.60K

miss

−100.00%

Consensus estimates